ProShares Ultra Nasdaq Biotechnology (United States) is an exchange-traded fund (ETF), with assets under management totaling $84.21 million.
Over the past 12 months, ProShares Ultra Nasdaq Biotechnology recorded a return of 86.54%, with its price trading between $50.08 and $109.84 during the same period.
The ETF is traded under the ticker BIB.